Active treatment in high-risk, early-stage CLL or SLL.

Saved in:
Bibliographic Details
Title: Active treatment in high-risk, early-stage CLL or SLL.
Authors: Stephens DM; UNC School of Medicine, Chapel Hill, North Carolina.
Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2026 Jun; Vol. 24 (4), pp. 259-261.
Publication Type: Interview
Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1543-0790